The problem
At least half the global population does not have access to essential health services. Many who do have access suffer undue financial hardship to receive care, sometimes pushing them into poverty. Access to affordable pharmaceutical drugs and medical devices also varies significantly by country. Companies have a key role to play in expanding affordable access to healthcare, as participants along the healthcare value chain (including drug and device manufacturers, providers, insurers, technology innovators and others), through the healthcare benefits offered employees, and through impact on growing the global economy (which allows more people to access and pay for healthcare)
How companies are rated
Ethos is using 185,798 unique data points since 2017 to rate companies, stocks and funds on access to affordable healthcare, including from these metrics:
Financial performance
r =
Company ratings 1-yr return
Top 10 for access to affordable healthcare
Top 50 for access to affordable healthcare
S&P 500 Index
Bottom 50 for access to affordable healthcare
Bottom 10 for access to affordable healthcare
Access to affordable healthcare has a slight positive correlation (
) with financial returns, meaning companies that perform better in this impact area tend to perform slightly better financially
Data partners and sources
What this formula is about
access to healthcare
universal access
healthcare affordability
UN Sustainable Development Goal 3